IP Library Assignment 032250/0584
Patent Assignment
Reel/Frame 032250/0584

Change of Name

Recorded: 2014-02-11 Pages: 4
Assignor
ENGENEIC GENE THERAPY PTY LIMITED
Executed: 2004-05-13
Assignee
ENGENEIC MOLECULAR DELIVERY PTY LTD
96 PRAIRIE VALE ROAD, BOSSLEY PARK, SYDNEY, NSW 2176, AUSTRALIA
Covered Properties (3)
Methods for Targeted in Vitro and in Vivo Drug Delivery to Mammalian Cells Via Bacterially Derived Intact Minicells
Patent: 8,772,013 →
Application: 10/588,028 →
Publication: US 2008/0051469
Targeted Delivery of Drugs, Therapeutic Nucleic Acids and Functional Nucleic Acids to Mammalian Cells via Intact Killed Bacterial Cells
Patent: 9,878,043 →
Application: 11/765,635 →
Publication: US 2008/0038296
Bacterially Derived Intact Minicells That Encompass Plasmid Free Functional Nucleic Acid for in Vivo Delivery to Mammalian Cells
Patent: 8,735,566 →
Application: 12/053,197 →
Publication: US 2008/0299084
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 30, 2007
From: BRAHMBHATT, HIMANSHU; MACDIARMID, JENNIFER
To: ENGENEIC GENE THERAPY PTY LIMITED
Reel/Frame 019325/0889 →
Assignment of Assignor's Interest Sep 13, 2007
From: BRAHMBHATT, HIMANSHU; MACDIARMID, JENNIFER
To: ENGENEIC GENE THERAPY PTY LIMITED
Reel/Frame 019822/0821 →
Assignment of Assignor's Interest Jul 14, 2008
From: BRAHMBHATT, HIMANSHU; MACDIARMID, JENNIFER; HULF, TOBY
To: ENGENEIC THERAPY PTY. LTD.
Reel/Frame 021232/0839 →